IDEXX Laboratories has retired 44.4% of its shares since 1999, from 141,703,436 to 78,781,116.
| Fiscal year | Date | Shares outstanding | Filing | |
|---|---|---|---|---|
| 1999 | 2000-03-23 | 141,703,436 | 10-K | cover page |
| 2000 | 2001-03-26 | 131,217,216 | 10-K | cover page |
| 2001 | 2002-03-20 | 135,775,856 | 10-K | cover page |
| 2002 | 2003-03-17 | 136,094,864 | 10-K | cover page |
| 2003 | 2004-01-30 | 138,813,356 | 10-K | cover page |
| 2004 | 2005-02-28 | 131,635,696 | 10-K | cover page |
| 2005 | 2006-02-22 | 127,408,808 | 10-K | cover page |
| 2006 | 2007-02-16 | 124,554,040 | 10-K | cover page |
| 2007 | 2008-02-15 | 121,908,610 | 10-K | cover page |
| 2008 | 2009-02-12 | 118,257,818 | 10-K | cover page |
| 2009 | 2010-02-12 | 116,122,638 | 10-K | cover page |
| 2010 | 2011-02-11 | 114,670,678 | 10-K | |
| 2011 | 2012-02-10 | 110,108,090 | 10-K | |
| 2012 | 2013-02-08 | 109,158,688 | 10-K | |
| 2013 | 2014-02-07 | 103,199,726 | 10-K | |
| 2014 | 2015-02-06 | 94,251,202 | 10-K | |
| 2015 | 2016-02-05 | 89,638,022 | 10-K | |
| 2016 | 2017-02-06 | 88,005,221 | 10-K | |
| 2017 | 2018-02-06 | 87,122,794 | 10-K | |
| 2018 | 2019-02-12 | 86,006,526 | 10-K | |
| 2019 | 2020-02-10 | 85,329,642 | 10-K | |
| 2020 | 2021-02-09 | 85,426,080 | 10-K | |
| 2021 | 2022-02-02 | 84,249,085 | 10-K | |
| 2022 | 2023-02-10 | 82,903,371 | 10-K | |
| 2023 | 2024-02-12 | 83,089,381 | 10-K | |
| 2024 | 2025-02-12 | 81,328,233 | 10-K | |
| 2025 | 2026-02-13 | 79,624,034 | 10-K |
Source: all 10-K filings of IDEXX Laboratories on EDGAR. Download this series as CSV. Licence CC BY 4.0, credit Buyback Radar.
Loading the chart from TradingView…
All-time chart by TradingView. Open it on TradingView →
Yes. IDEXX Laboratories has 1.3% fewer shares outstanding than twelve months ago, 78,781,116 as of July 31, 2026. Over five years the share count is down 7.1%.
Net of every new share it issued, IDEXX Laboratories has 62.9 million fewer shares than at its 1999 peak. That is 44.4% of the company. Since fiscal 2008 alone it bought back about 58.6 million shares, while the count fell by 39.5 million. The difference went to employees and other new shares.
78,781,116 shares, as of July 31, 2026, from the cover page of its latest 10-Q. At the 1999 peak it had 141,703,436.
Each share is a bigger slice of the company. Someone who held IDEXX Laboratories stock in 1999 owns 1.8 times as much of the business today without buying another share. Whether that was a good use of cash depends on the price paid.
IDEXX Laboratories ranks No. 98 of 251 companies on Buyback Radar by share of the company retired since its peak. Close to it on the list: Goldman Sachs (44.7%), Apple (44.6%), PVH (44.1%), Capri (43.6%).
Every answer is computed from IDEXX Laboratories' own SEC filings and rebuilt every Monday. Latest count: 10-Q on EDGAR.
From the latest 13F filings. All superinvestors.
The numbers say what happened. The story says whether it can continue. We cover companies like IDEXX Laboratories in depth on Cannibal Stocks.
Read Cannibal Stocks